Cargando…
Amyloid positron emission tomography candidates may focus more on benefits than risks of results disclosure
INTRODUCTION: Given mounting calls to disclose biomarker test results to research participants, we explored factors underlying decisions by patients with mild cognitive impairment to receive amyloid imaging results. METHODS: Prospective, qualitative interviews were conducted with 59 participants (30...
Autores principales: | Lingler, Jennifer H., Roberts, J. Scott, Kim, Hyejin, Morris, Jonna L., Hu, Lu, Mattos, Meghan, McDade, Eric, Lopez, Oscar L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072672/ https://www.ncbi.nlm.nih.gov/pubmed/30094328 http://dx.doi.org/10.1016/j.dadm.2018.05.003 |
Ejemplares similares
-
Disclosure of preclinical Alzheimer's disease biomarker results in research and clinical settings: Why, how, and what we still need to know
por: Erickson, Claire M., et al.
Publicado: (2021) -
Phenoconversion from probable rapid eye movement sleep behavior disorder to mild cognitive impairment to dementia in a population-based sample
por: Jung, Youngsin, et al.
Publicado: (2017) -
An individual with human immunodeficiency virus, dementia, and central nervous system amyloid deposition
por: Turner, Raymond Scott, et al.
Publicado: (2016) -
Practical algorithms for amyloid β probability in subjective or mild cognitive impairment
por: Maserejian, Nancy, et al.
Publicado: (2019) -
Obesity impacts brain metabolism and structure independently of amyloid and tau pathology in healthy elderly
por: Pegueroles, Jordi, et al.
Publicado: (2020)